Ameriprise Financial Inc Medicinova Inc Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.6 $13,020 - $16,120	-6,200 Reduced 24.31%	19,300 $42,000
Q2 2022 Aug 15, 2022	SELL	$2.31 - $3.14 $3,927 - $5,338	-1,700 Reduced 6.25%	25,500 $65,000
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.42 $19,575 - $33,150	-7,500 Reduced 21.61%	27,200 $73,000
Q3 2021 Nov 15, 2021	BUY	$3.4 - $4.24 $4,420 - $5,512	1,300 Added 3.89%	34,700 $132,000
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $10,152 - $13,878	2,700 Added 8.79%	33,400 $142,000
Q1 2021 May 17, 2021	BUY	$4.81 - $8.74 $1,202 - $2,185	250 Added 0.82%	30,700 $155,000
Q4 2020 Feb 12, 2021	BUY	$5.03 - $6.31 $153,163 - $192,139	30,450 New	30,450 $159,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.